UMB Pushing Biomedical Technology Forward
The University of Maryland, Baltimore (UMB) is at the forefront of supporting the biomedical research industry in Baltimore.UMB and the University of Maryland Baltimore County (UMBC) were jointly awarded a four-year, $4 million Research Evaluation and Commercialization Hubs (REACH) grant from the National Institutes of Health (NIH) to advance the biomedical entrepreneurship and innovation economy in the Baltimore region.This grant will be used to build on the work that began when UMBC and the University of Maryland School of Medicine (UMSOM) received a $13 million NIH Common Fund Faculty Institutional Recruitment for Sustainable Transformation (FIRST) grant in 2022 to enhance recruitment and training of junior faculty from groups underrepresented in biomedical science.UMB will also use the grant to create the University of Maryland, Baltimore Life Science Discovery (UM-BILD) Accelerator program’s “proof-of-concept” hub — one of only five NIH-funded proof-of-concept hubs in the U.S. — in the University of Maryland BioPark and at bwtech@UMBC.Jim Hughes, chief enterprise and economic development officer and senior vice president for UMB, spoke to the Baltimore Mayor and City Council recently about the impact of the grant.
More from Youtube
- 1:21:17University of Maryland, Baltimore 1807 Commission ReportOn April 4, 2024, the University of Maryland, Baltimore 1807 Commission on Slavery and Racism reported its initial findings, including connections to slavery and racist ideologies of significant figures in the university's history. Speakers included UMB President Bruce E. Jarrell, and UMB Chief Equity, Diversity, and Inclusion Officer and Vice President Diane Forbes Berthoud.
- 1:56:14The Future of Work at the University of Maryland, BaltimoreOn March 28, 2024, the University of Maryland, Baltimore Future of Work Committee held its third and final hybrid town hall. During the two hour event the committee reviewed recommendations and discussed whether specific recommendations were approved, rejected, or subject to further review. Roughly 30 in-person and 100 virtual attendees asked a wide range of questions about implementation plans and offered additional suggestions. Speakers included UMB Provost and Exec. VP Roger J. Ward, Chief Business and Finance Officer and VP Dawn M. Rhodes, and Chief Human Resources Officer Malika S. Monger.
- 1:00:45Faculty Experience Survey Town HallOn March 27, 2024, University of Maryland, Baltimore (UMB) Chief Equity, Diversity, and Inclusion Officer and Vice President Diane Forbes Berthoud, PhD, MA, shared the results of the 2023 Faculty Experience Survey with UMB faculty and staff in a hybrid town hall meeting.
- 1:56:08Future of Work Town HallOn March 28, 2024, the University of Maryland, Baltimore held the third of three hybrid town hall meetings to review the report of the university's Future of Work Committee.
- 58:52UMB Face to Face with Dr. Bruce Jarrell featuring Sarah L.J. MichelOn the March 28, 2024 edition of Virtual Face to Face with President Bruce Jarrell, University of Maryland, Baltimore President Bruce E. Jarrell, MD, FACS talks with University of Maryland School of Pharmacy Dean Sarah L. J. Michel, PhD, about the state of pharmacy education and her plans to attract students, enhance opportunities, boost research, and promote "Pharmapreneurship."
- 58:42The Dean’s List: A Conversation with UM School of Pharmacy Dean Sarah MichelOn this episode of Virtual Face to Face, UMB President Bruce E. Jarrell, MD, FACS, sits down with University of Maryland School of Pharmacy (UMSOP) Dean Sarah L.J. Michel, PhD, as she talks about her vision for the future of pharmacy education and research. Now in her sixth month as dean, Michel discusses her five-part plan for the future of the school, including: • A comprehensive reimagining of the Doctor of Pharmacy (PharmD) curriculum • Increasing the size and scope of research • Expanding master’s and certificate programs • Advancing equity, diversity, and inclusion • Improving alumni engagement Michel is an internationally recognized scientist regarding the role metals play in the regulation of chronic inflammation, cancer, and neurodegenerative diseases. A recent Food and Drug Administration (FDA) clinical trial she headed led the FDA to issue new guidance on how generic nanomedicines should be evaluated for approval. During her 19 years at UMSOP, Michel has also been a leader in all aspects of education, establishing the annual “Spring Into Science” event with the National Science Foundation and helping to win a National Institutes of Health Initiative for Maximizing Student Development T32 grant to train students from groups underrepresented in health-related sciences.